[1]
C. Cifani, S. Costantino, and M. Massi, et al., “Commercially available lipid formulations of amphotericin B: are they bioequivalent and therapeutically equivalent?”, Acta Biomed, vol. 83, no. 2, pp. 154–163, Dec. 2012, Accessed: Jul. 27, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/actabiomedica/article/view/2376